A share price of 89bio Inc [ETNB] is currently trading at $14.87, saw in change for the day. An important factor to consider is whether the stock is rising or falling in short-term value. The ETNB shares have gain 85.41% over the last week, with a monthly amount glided 61.81%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Goldman started tracking the stock with Neutral rating on March 14, 2025, and set its price target to $11. On March 13, 2025, Citigroup initiated with a Buy rating and assigned a price target of $25 on the stock. Wolfe Research started tracking the stock assigning a Outperform rating. RBC Capital Mkts downgraded its rating to Sector Perform for this stock on January 12, 2024, and downed its price target to $15. In a note dated October 10, 2023, Oppenheimer downgraded an Perform rating on this stock.
89bio Inc experienced fluctuations in its stock price throughout the past year between $4.16 and $15.06. Currently, Wall Street analysts expect the stock to reach $14.5 within the next 12 months. 89bio Inc [NASDAQ: ETNB] shares were valued at $14.87 at the most recent close of the market. An investor can expect a potential drop of -2.49% based on the average ETNB price forecast.
Analyzing the ETNB fundamentals
Gross Profit Margin for this corporation currently stands at -1.24% with Operating Profit Margin at -22175.05%, Pretax Profit Margin comes in at -21374.05%, and Net Profit Margin reading is -21438.38%. To continue investigating profitability, this company’s Return on Assets is posted at -0.75, Equity is -0.94 and Total Capital is -0.83. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 14.83 points at the first support level, and at 14.80 for the second support level. However, for the 1st resistance point, the stock is sitting at 14.91, and for the 2nd resistance point, it is at 14.95.
Ratios To Look Out For
To put it in perspective, the Current Ratio for 89bio Inc [NASDAQ:ETNB] is 15.19. On the other hand, the Quick Ratio is 15.19, and the Cash Ratio is 3.26.
Transactions by insiders
Recent insider trading involved Le-Nguyen Quoc, that happened on Jul 15 ’25 when 10461.0 shares were sold. Officer, QUOC LE-NGUYEN completed a deal on Jul 15 ’25 to buy 10461.0 shares. Meanwhile, Le-Nguyen Quoc sold 15329.0 shares on Apr 15 ’25.
